Ganciclovir
NDC 42023-173, Ganciclovir, injection, powder, lyophilized, for solution, from Par Health USA, LLC.
- Product NDC
- 42023-173
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204950
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42023-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANCICLOVIR SODIUM500 mg/10mL
Pharmacologic classes
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42023-173-25 | 42023017325 | 25 VIAL, SINGLE-DOSE in 1 CARTON (42023-173-25) / 10 mL in 1 VIAL, SINGLE-DOSE (42023-173-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/87afd103-6e64-444f-971d-0e732e9ae995Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=42023-173
Use it
Look up 42023-173 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42023-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42023-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.